Camber Pharma Launches Generic Combivir®
Piscataway, NJ, September 20, 2014– Camber Pharmaceuticals announces that it has launched Lamivudine/Zidovudine, USP 150 mg/300mg tablets. The drug is the generic version of Combivir® tablets.
Lamivudine/Zidovudine is available only in 60 count bottle.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection